Amneal Pharmaceuticals (AMRX) Shares Outstanding (Diluted Average) (2018 - 2026)

Amneal Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $328.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 1.53% year-over-year to $328.9 million; the TTM figure through Mar 2026 stood at $328.9 million (up 1.53% YoY), while the FY2025 annual figure was $324.8 million, up 5.12% from the prior year.
• Shares Outstanding (Diluted Average) was $328.9 million for Q1 2026 at Amneal Pharmaceuticals, up from $324.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $328.9 million in Q1 2026 to a low of $149.9 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $241.4 million across 5 years, with a median of $307.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) dropped 0.88% in 2022, then jumped 102.01% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $150.9 million in 2022, then climbed by 16.69% to $176.1 million in 2023, then surged by 75.42% to $309.0 million in 2024, then advanced by 5.12% to $324.8 million in 2025, then climbed by 1.27% to $328.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $328.9 million (Q1 2026), $324.8 million (Q4 2025), and $324.8 million (Q3 2025), per Business Quant data.